Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Portrait de Michael Severino
Age : 54
Public asset : 13,221,847 USD
Country of residence : Unknown
Linked companies : AbbVie Inc. - Avantor, Inc.

Biography of Michael Severino 
Dr. Michael E. Severino, MD, is an Independent Director at Avantor, Inc. and a Vice Chairman-Management Board & President at AbbVie, Inc. He is on the Board of Directors at Avantor, Inc., Biotechnology Innovation Organization and The Field Museum of Natural History. Dr. Severino was previously employed as a Chief Medical Officer & SVP-Global Development by Amgen, Inc., a Senior Vice President by Amgen Ventures LLC, and a Senior Director by Merck Research Laboratories Massachusetts LLC. He received his undergraduate degree from the University of Maryland and a doctorate degree from The Johns Hopkins University.


Current positions of Michael Severino 
Holdings of Michael Severino 
Michael Severino : Personal Network 
Most Read News 
09/22WILLIAM ACKMAN : Ackman's Pershing Square fund surges as Universal soars in stock debut
RE
09/24CATHIE WOOD : Chinese crackdown on bitcoin another blow to Cathie Wood's ARK ETF
RE
09/14BRAD SMITH : Microsoft to buy back up to $60 billion in shares; names Brad Smith vice chair
RE
09/13MARTIN SORRELL : Sorrell's S4 Capital raises annual profit outlook for a third time
RE
09/14CATHIE WOOD : ARK Invest's Wood expects market rotation back to growth stocks
RE
09/22CATHIE WOOD : ARK's Cathie Wood says Wall Street not in a bubble
RE
09/24ELON MUSK : New semiconductor plants will end global auto chip shortage next year -Tesla's Musk
RE
09/21JEFF BEZOS : UK's Johnson discussed taxation with Amazon's Bezos
RE
09/17STELIOS HAJI-IOANNOU : EasyJet shareholder Stelios Haji-Ioannou shuns rights issue -source
RE
09/24BARRY DILLER : Stock Futures Weaken After Evergrande Payment Deadline Passes
DJ
More news


© 2021 People and Ownership :   
Michael Severino : Connections 


Latest news about Michael Severino 
07/16ABBVIE : FDA Does Not Meet PDUFA Action Date for AbbVie's Rinvoq Supplemental New-Drug Application
MT
07/16AbbVie Says FDA Didn't Meet Action Date for Dermatitis Treatment Application
DJ
06/25AbbVie Says FDA Won't Meet Action Dates for Arthritis Drug Rinvoq
DJ
04/02FDA Extends Review of AbbVie's Skin Drug Application
DJ
2020ABBVIE : Insider Sales at AbbVie (ABBV) are Significant
MT
2020INSIDER TRENDS : Insider Prolongs 90-Day Selling Trend at AbbVie
MT
2020Avantor, Inc. Appoints Michael Severino as Class II Director
CI
More news